Hence, multi-faceted functionalities regulated by EGFR signaling contribute differently to tumor progression and impact on therapy response, thereby providing valuable avenues for treatment of advanced HNSCC. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.